Stay updated on GeneNews LimitedPress Releases
Sign up to get notified when there's something new on the GeneNews LimitedPress Releases page.
Latest updates to the GeneNews LimitedPress Releases page
- Check7 days agoChange DetectedThe page now highlights a new study indicating that Genentech’s Lunsumio and Polivy combination significantly prolongs remission for patients with relapsed or refractory large B-cell lymphoma, while the previous study on the Perjeta-based regimen's impact on HER2-positive early-stage breast cancer has been removed.SummaryDifference9%
- Check14 days agoChange DetectedThe webpage has been updated to include new information about Genentech's advancements in Parkinson's disease treatment and a recent study update, while previous content regarding influenza transmission and Alzheimer's advancements has been removed.SummaryDifference67%
- Check22 days agoChange DetectedThe page has added a section on 'Equitable Care' while removing references to 'Health Impact'.SummaryDifference0.8%
- Check29 days agoChange DetectedThe webpage has been updated with new significant data regarding Genentech's treatments, including survival benefits for various cancers and multiple sclerosis, while older updates have been removed.SummaryDifference67%
- Check36 days agoChange DetectedThe page now includes updated information on FDA approvals for Genentech's Columvi and Susvimo, while the previous approval for Evrysdi has been removed.SummaryDifference15%
- Check43 days agoChange DetectedThe page has been updated to reflect a new FDA advisory committee meeting update regarding Genentech's Columvi for lymphoma, replacing a previous publication about Gazyva's superiority in lupus nephritis.SummaryDifference11%
Stay in the know with updates to GeneNews LimitedPress Releases
Enter your email address, and we'll notify you when there's something new on the GeneNews LimitedPress Releases page.